DNA-PK inhibitor, M3814, as a radiation sensitizer in the treatment of neuroendocrine tumors

被引：0
|
作者：
Rychahou, Piotr [1 ]
Chauhan, Aman [2 ,3 ]
Chow, Zeta [1 ]
Izumi, Tadahidi [4 ]
Chen, Quan [5 ]
Lee, Eun Y. [6 ]
Napier, Dana [6 ]
Anthony, Lowell B. [2 ,3 ]
Cavnar, Michael J. [1 ]
Kunos, Charles [7 ]
Evers, B. Mark [1 ,3 ]
机构：
[1] Univ Kentucky, Dept Surg, Lexington, KY USA
[2] Univ Kentucky, Dept Internal Med Med Oncol, Lexington, KY USA
[3] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA
[4] Univ Kentucky, Markey Canc Ctr, Dept Toxicol & Canc Biol, Lexington, KY USA
[5] Univ Kentucky, Dept Radiat Med, Lexington, KY USA
[6] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY USA
[7] NIH, Washington, DC USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-6402
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6402
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The effects of the DNA-PK inhibitor vanillin after treatment with methyl methane sulphonate
    Linek, B.
    Nikolova, T.
    Kaina, B.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 77 - 77
  • [32] Inhibition of DNA-PKcs by M3814 potentiates efficacy of ionizing radiation in patient derived xenografts of melanoma brain metastases
    Ji, Jianxiong
    Smith, Emily J.
    Sarkaria, Paige
    Mladek, Ann C.
    Talele, Surabhi
    Swanson, Katelyn
    Mohammad, Afroz S.
    He, Lihong
    Hu, Zeng
    Bakken, Katrina K.
    Gupta, Shiv K.
    Burgenske, Danielle M.
    Kitange, Gaspar J.
    Elmquist, William F.
    Sarkaria, Jann N.
    CANCER RESEARCH, 2020, 80 (16)
  • [33] Quantitation of the DNA-dependent protein kinase inhibitor peposertib (M3814) and metabolite in human plasma by LC-MS/MS
    Christner, Susan M.
    Parise, Robert A.
    Bakkenist, Christopher J.
    Davis, S. Lindsey
    Feng, Ye
    Synold, Timothy
    Gore, Steven
    Beumer, Jan H.
    BIOMEDICAL CHROMATOGRAPHY, 2024, 38 (12)
  • [34] INHIBITION OF DNA-PKCS BY M3814 POTENTIATES EFFICACY OF IONIZING RADIATION IN PATIENT-DERIVED XENOGRAFTS OF MELANOMA BRAIN METASTASES
    Ji, Jianxiong
    Smith, Emily
    Sarkaria, Paige
    Mladek, Ann
    Talele, Surabhi
    Swanson, Katelyn
    Mohammad, Afroz S.
    Zhang, Wenjuan
    He, Lihong
    Hu, Zeng
    Zhao, Yu
    Chen, Jiajia
    Connors, Margaret A.
    Porath, Kendra A.
    Bakken, Katrina K.
    Dragojevic, Sonja
    Carlson, Brett L.
    Gupta, Shiv K.
    Burgenske, Danielle M.
    Kitange, Gaspar J.
    Elmquist, William F.
    Sarkaria, Jann
    NEURO-ONCOLOGY, 2020, 22 : 86 - 86
  • [35] Radiation and Chemo-Sensitizing Effects of DNA-PK Inhibitors Are Proportional in Tumors and Normal Tissues
    Baker, Jennifer H. E.
    Kyle, Alastair H.
    Liu, Nannan A.
    Wang, Taixiang
    Liu, Xinhe
    Teymori, Sevin
    Banath, Judit P.
    Minchinton, Andrew I.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (09) : 1230 - 1240
  • [36] A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors
    Samuels, Michael
    Falkenius, Johan
    Bar -Ad, Voichita
    Dunst, Juergen
    van Triest, Baukelien
    Yachnin, Jeffrey
    Rodriguez-Gutierrez, Almudena
    Kuipers, Mirjam
    You, Xiaoli
    Sarholz, Barbara
    Locatelli, Giuseppe
    Becker, Andreas
    Troost, Esther G. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (03): : 743 - 756
  • [37] Discovery of VX-984: A novel, selective DNA-PK inhibitor for the treatment of cancer
    Maxwell, John
    Cottrell, Kevin
    Xu, Jinwang
    Arimoto, Rieko
    Boucher, Brian
    Chandupatla, Kishan
    Cochran, John
    Damagnez, Veronique
    Engtrakul, Juntyma
    Ford, Pamella
    Furey, Brinley
    Giroux, Simon
    Green, Jeremy
    Henry, Larry
    Hillier, Shawn
    Hogan, James
    Hoover, Russell
    Jackson, Katrina
    Markland, William
    Moody, Cameron
    Morris, Mark
    Pierce, Albert
    Shannon, Dean
    Stearns, Ralph
    Waal, Nathan
    Wang, Yuxin
    Wood, Mark
    Boucher, Diane
    Charifson, Paul
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [38] DNA-PK and ATM are required for radiation-enhanced integration
    Nimura, Y
    Ismail, SM
    Kurimas, A
    Chen, DJ
    Stevens, CW
    RADIATION RESEARCH, 2002, 157 (05) : 562 - 567
  • [39] AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity
    Jacqueline H. L. Fok
    Antonio Ramos-Montoya
    Mercedes Vazquez-Chantada
    Paul W. G. Wijnhoven
    Valeria Follia
    Neil James
    Paul M. Farrington
    Ankur Karmokar
    Sophie E. Willis
    Jonathan Cairns
    Jenni Nikkilä
    David Beattie
    Gillian M. Lamont
    M. Raymond V. Finlay
    Joanne Wilson
    Aaron Smith
    Lenka Oplustil O’Connor
    Stephanie Ling
    Stephen E. Fawell
    Mark J. O’Connor
    Simon J. Hollingsworth
    Emma Dean
    Frederick W. Goldberg
    Barry R. Davies
    Elaine B. Cadogan
    Nature Communications, 10
  • [40] AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity
    Fok, Jacqueline H. L.
    Ramos-Montoya, Antonio
    Vazquez-Chantada, Mercedes
    Wijnhoven, Paul W. G.
    Follia, Valeria
    James, Neil
    Farrington, Paul M.
    Karmokar, Ankur
    Willis, Sophie E.
    Cairns, Jonathan
    Nikkila, Jenni
    Beattie, David
    Lamont, Gillian M.
    Finlay, M. Raymond, V
    Wilson, Joanne
    Smith, Aaron
    O'Connor, Lenka Oplustil
    Ling, Stephanie
    Fawell, Stephen E.
    O'Connor, Mark J.
    Hollingsworth, Simon J.
    Dean, Emma
    Goldberg, Frederick W.
    Davies, Barry R.
    Cadogan, Elaine B.
    NATURE COMMUNICATIONS, 2019, 10 (1)
12345